NO328180B1 - Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon - Google Patents

Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon Download PDF

Info

Publication number: NO328180B1
Authority: NO; Norway
Prior art keywords: barrier; implant according; semi; permeable; coating
Prior art date: 2003-10-02

Application number

NO20061899A

Other languages

English (en)

Norwegian (no)

Other versions

NO20061899L (no

Inventor

Lars Bruce

Olle Korsgren

Bo Nilsson

Adam Bruce

Original Assignee

Tikomed Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-02

Filing date

2006-04-28

Publication date

2009-12-28

2006-04-28 Application filed by Tikomed Ab filed Critical Tikomed Ab

2006-06-28 Publication of NO20061899L publication Critical patent/NO20061899L/no

2009-12-28 Publication of NO328180B1 publication Critical patent/NO328180B1/no

Links

239000007943 implant Substances 0.000 title claims abstract description 48
238000000034 method Methods 0.000 title claims abstract description 11
210000002808 connective tissue Anatomy 0.000 title abstract description 17
230000015572 biosynthetic process Effects 0.000 title abstract description 4
238000002513 implantation Methods 0.000 title description 4
230000004888 barrier function Effects 0.000 claims abstract description 66
238000000576 coating method Methods 0.000 claims abstract description 62
239000011248 coating agent Substances 0.000 claims abstract description 61
239000010936 titanium Substances 0.000 claims abstract description 45
229910052751 metal Inorganic materials 0.000 claims abstract description 25
239000002184 metal Substances 0.000 claims abstract description 25
238000009792 diffusion process Methods 0.000 claims abstract description 24
230000000975 bioactive effect Effects 0.000 claims abstract description 20
239000000126 substance Substances 0.000 claims abstract description 19
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 14
229910052719 titanium Inorganic materials 0.000 claims abstract description 14
239000000463 material Substances 0.000 claims abstract description 13
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 27
229940125396 insulin Drugs 0.000 claims description 14
102000004877 Insulin Human genes 0.000 claims description 13
108090001061 Insulin Proteins 0.000 claims description 13
235000015097 nutrients Nutrition 0.000 claims description 10
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
239000008280 blood Substances 0.000 claims description 8
210000004369 blood Anatomy 0.000 claims description 8
239000001301 oxygen Substances 0.000 claims description 8
229910052760 oxygen Inorganic materials 0.000 claims description 8
210000000056 organ Anatomy 0.000 claims description 7
230000008020 evaporation Effects 0.000 claims description 5
238000001704 evaporation Methods 0.000 claims description 5
238000001802 infusion Methods 0.000 claims description 3
238000005507 spraying Methods 0.000 claims description 3
229910045601 alloy Inorganic materials 0.000 claims description 2
239000000956 alloy Substances 0.000 claims description 2
238000000889 atomisation Methods 0.000 claims description 2
229910052715 tantalum Inorganic materials 0.000 claims description 2
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 2
229910052845 zircon Inorganic materials 0.000 claims 1
GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 claims 1
210000000496 pancreas Anatomy 0.000 abstract description 2
239000012528 membrane Substances 0.000 description 33
210000001519 tissue Anatomy 0.000 description 28
238000000502 dialysis Methods 0.000 description 16
239000008103 glucose Substances 0.000 description 15
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
210000004027 cell Anatomy 0.000 description 14
239000011148 porous material Substances 0.000 description 13
210000004204 blood vessel Anatomy 0.000 description 12
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 7
229940072056 alginate Drugs 0.000 description 7
235000010443 alginic acid Nutrition 0.000 description 7
229920000615 alginic acid Polymers 0.000 description 7
206010016654 Fibrosis Diseases 0.000 description 6
230000004761 fibrosis Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000004048 modification Effects 0.000 description 6
241001465754 Metazoa Species 0.000 description 5
230000000694 effects Effects 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
230000032258 transport Effects 0.000 description 5
239000011888 foil Substances 0.000 description 4
230000035699 permeability Effects 0.000 description 4
238000002054 transplantation Methods 0.000 description 4
239000002775 capsule Substances 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
230000008859 change Effects 0.000 description 3
239000012530 fluid Substances 0.000 description 3
230000007124 immune defense Effects 0.000 description 3
210000000987 immune system Anatomy 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000011575 calcium Substances 0.000 description 2
238000013461 design Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
210000004153 islets of langerhan Anatomy 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
239000004810 polytetrafluoroethylene Substances 0.000 description 2
229920001343 polytetrafluoroethylene Polymers 0.000 description 2
239000000843 powder Substances 0.000 description 2
230000002792 vascular Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000003951 Erythropoietin Human genes 0.000 description 1
108090000394 Erythropoietin Proteins 0.000 description 1
229920000544 Gore-Tex Polymers 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
230000002300 anti-fibrosis Effects 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
239000003364 biologic glue Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
238000009388 chemical precipitation Methods 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000000428 dust Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229940105423 erythropoietin Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000835 fiber Substances 0.000 description 1
230000003352 fibrogenic effect Effects 0.000 description 1
239000007789 gas Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940124589 immunosuppressive drug Drugs 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000011694 lewis rat Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000001690 micro-dialysis Methods 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
210000002976 pectoralis muscle Anatomy 0.000 description 1
238000011056 performance test Methods 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
229920005597 polymer membrane Polymers 0.000 description 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000009291 secondary effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000009958 sewing Methods 0.000 description 1
210000005070 sphincter Anatomy 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000010409 thin film Substances 0.000 description 1
230000007998 vessel formation Effects 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1
238000003466 welding Methods 0.000 description 1
229910052726 zirconium Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Transplantation (AREA)
Animal Behavior & Ethology (AREA)
Oral & Maxillofacial Surgery (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Prostheses (AREA)
Materials For Medical Uses (AREA)
External Artificial Organs (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)

NO20061899A 2003-10-02 2006-04-28 Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon NO328180B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0302599A SE526959C2 (sv)	2003-10-02	2003-10-02	Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
PCT/SE2004/001418 WO2005030283A1 (en)	2003-10-02	2004-10-04	Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation

Publications (2)

Publication Number	Publication Date
NO20061899L NO20061899L (no)	2006-06-28
NO328180B1 true NO328180B1 (no)	2009-12-28

Family

ID=29247003

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061899A NO328180B1 (no)	2003-10-02	2006-04-28	Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon

Country Status (25)

Country	Link
US (1)	US7955613B2 (uk)
EP (1)	EP1667746B1 (uk)
JP (1)	JP4837563B2 (uk)
KR (1)	KR101181535B1 (uk)
CN (1)	CN100536937C (uk)
AT (1)	ATE405301T1 (uk)
AU (1)	AU2004275685B2 (uk)
BR (1)	BRPI0415004A (uk)
CA (1)	CA2539150C (uk)
DE (1)	DE602004016008D1 (uk)
DK (1)	DK1667746T3 (uk)
ES (1)	ES2313072T3 (uk)
IL (1)	IL174488A0 (uk)
MX (1)	MXPA06003665A (uk)
NO (1)	NO328180B1 (uk)
NZ (1)	NZ546775A (uk)
PL (1)	PL1667746T3 (uk)
PT (1)	PT1667746E (uk)
RS (1)	RS20060235A (uk)
RU (1)	RU2349349C2 (uk)
SE (1)	SE526959C2 (uk)
SI (1)	SI1667746T1 (uk)
UA (1)	UA81982C2 (uk)
WO (1)	WO2005030283A1 (uk)
ZA (1)	ZA200602759B (uk)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3537986A4 (en) *	2016-11-10	2020-06-03	ViaCyte, Inc.	PDX1 PANCREATIC ENDODERM CELLS IN CELL INSERTION DEVICES AND METHOD THEREFOR

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE515227C2 (sv)	1999-04-28	2001-07-02	Bruce Medical Ab	Kropp för åstadkommande av in- och tillväxt av benvävnad och/ eller bindväv och sätt för framställning av kroppen
JP4543152B2 (ja) *	2004-08-20	2010-09-15	独立行政法人産業技術総合研究所	透明チタン被覆生体適合化材料
EP2125056B1 (en) *	2007-02-19	2015-11-18	Ticapex AB	Implant assembly
EP2134295B1 (en) *	2007-03-09	2012-12-19	The University of Akron	Bio-artificial pancreas and a procedure for preparation of same
CA2698212A1 (en)	2007-08-23	2009-02-26	Intrexon Corporation	Methods and compositions for diagnosing disease
NZ584848A (en)	2007-09-28	2012-09-28	Intrexon Corp	Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
RU2525737C1 (ru) *	2013-05-22	2014-08-20	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.)	Способ изготовления внутрикостного стоматологического имплантата
RU2526252C1 (ru) *	2013-05-30	2014-08-20	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.)	Способ изготовления внутрикостных имплантатов с многослойным покрытием
JP7084566B2 (ja) *	2017-05-29	2022-06-15	創生ライフサイエンス株式会社	生体適合性高分子材料のマーキング方法
JP7625186B2 (ja)	2019-09-27	2025-02-03	イスラテクノロジーズ，インコーポレイテッド	バイオ人工膵臓
US12485274B2 (en)	2021-03-08	2025-12-02	Samsung Electronics Co., Ltd.	Apparatus and method with electrical stimulus

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4752292A (en) *	1983-01-24	1988-06-21	Icu Medical, Inc.	Medical connector
SE450623B (sv) *	1984-11-07	1987-07-13	Dan Lundgren	Element for kontrollerad vevnadsinvext i kirurgiskt intervenerade omraden
US5611347A (en) *	1989-07-25	1997-03-18	Smith & Nephew, Inc.	Zirconium oxide and zirconium nitride coated percutaneous devices
JP3508023B2 (ja) *	1990-10-31	2004-03-22	バクスター、インターナショナル、インコーポレイテッド	密接血管化埋め込み材料
EP0585368B1 (en) *	1991-04-25	1997-08-06	Brown University Research Foundation	Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
SG47955A1 (en) *	1991-06-24	1998-04-17	American Cyanamid Co	Implant compositions containing a biologically active protein peptide or polypeptide
US5429821A (en) *	1992-05-29	1995-07-04	The Regents Of The University Of California	Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
US5387327A (en) *	1992-10-19	1995-02-07	Duquesne University Of The Holy Ghost	Implantable non-enzymatic electrochemical glucose sensor
RU2040277C1 (ru)	1992-12-27	1995-07-25	Товарищество с ограниченной ответственностью "МиТ" (Медицина и Технология)	Способ изготовления материала для имплантата с электретными свойствами для остеосинтеза
US5876742A (en) *	1994-01-24	1999-03-02	The Regents Of The University Of California	Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
AUPM425294A0 (en) *	1994-03-04	1994-03-31	Australian National University, The	In-vitro angiogenesis assay
CA2190628C (en) *	1995-06-07	2000-05-30	Mark D. Butler	An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
US5855613A (en) *	1995-10-13	1999-01-05	Islet Sheet Medical, Inc.	Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
RU2113830C1 (ru)	1996-04-02	1998-06-27	Самарский государственный аэрокосмический университет им.С.П.Королева	Зубной имплантат
RU2109495C1 (ru)	1996-07-19	1998-04-27	Наум Абрамович Иофис	Искусственный клапан сердца и способ его изготовления
RU2117456C1 (ru)	1996-11-18	1998-08-20	Жусев Андрей Иванович	Пластиночный эндооссальный имплантант
RU2162715C2 (ru) *	1997-08-20	2001-02-10	Трофимов Виктор Венедиктович	Состав для покрытия пористых имплантатов
RU2142867C1 (ru)	1998-02-23	1999-12-20	Суслов Анатолий Григорьевич	Комбинированный (режуще-деформирующий) метчик
WO2000051659A1 (en) *	1999-03-05	2000-09-08	Matson Louis R	Surface-modified bioactive surgical implants suppressing tissue growth
RU2157245C1 (ru)	1999-03-05	2000-10-10	Антонив Василий Федорович	Способ изготовления имплантатов
RU2185127C2 (ru)	1999-07-19	2002-07-20	Нижегородская государственная медицинская академия	Винтовой зубной имплантат
DE19950386A1 (de) *	1999-10-19	2001-05-10	Miladin Lazarov	Biokompatibler Gegenstand
US20020000404A1 (en) *	2000-03-17	2002-01-03	Michael Mutsakis	Filtration element for severe service applications
US20020037383A1 (en) *	2000-04-14	2002-03-28	Spillman William B.	Self-assembled thin film coating to enhance the biocompatibility of materials
RU2191607C2 (ru)	2000-06-23	2002-10-27	Гюнтер Виктор Эдуардович	Носитель клеточных культур искусственных внутренних органов
US6649384B2 (en)	2000-07-05	2003-11-18	Islet Technology, Inc.	System and method for encapsulating biological material by applying electrostatic charge to capsules
EP1381402B1 (en) *	2001-04-27	2009-11-18	Vivoxid Oy	Method for improvement of soft tissue attachment and implants making use of said method
US7163688B2 (en) *	2001-06-22	2007-01-16	Alza Corporation	Osmotic implant with membrane and membrane retention means
SE0200269D0 (sv)	2002-01-31	2002-01-31	Ellem Bioteknik Ab	Material for implantation
US7458991B2 (en) *	2002-02-08	2008-12-02	Howmedica Osteonics Corp.	Porous metallic scaffold for tissue ingrowth

2003
- 2003-10-02 SE SE0302599A patent/SE526959C2/sv not_active IP Right Cessation
2004
- 2004-04-10 UA UAA200604785A patent/UA81982C2/uk unknown
- 2004-10-04 RS YUP-2006/0235A patent/RS20060235A/sr unknown
- 2004-10-04 EP EP04775510A patent/EP1667746B1/en not_active Expired - Lifetime
- 2004-10-04 ES ES04775510T patent/ES2313072T3/es not_active Expired - Lifetime
- 2004-10-04 MX MXPA06003665A patent/MXPA06003665A/es active IP Right Grant
- 2004-10-04 DE DE602004016008T patent/DE602004016008D1/de not_active Expired - Lifetime
- 2004-10-04 PL PL04775510T patent/PL1667746T3/pl unknown
- 2004-10-04 NZ NZ546775A patent/NZ546775A/en not_active IP Right Cessation
- 2004-10-04 US US10/574,114 patent/US7955613B2/en not_active Expired - Fee Related
- 2004-10-04 CN CNB200480028566XA patent/CN100536937C/zh not_active Expired - Fee Related
- 2004-10-04 CA CA2539150A patent/CA2539150C/en not_active Expired - Fee Related
- 2004-10-04 JP JP2006532233A patent/JP4837563B2/ja not_active Expired - Fee Related
- 2004-10-04 AT AT04775510T patent/ATE405301T1/de active
- 2004-10-04 SI SI200430926T patent/SI1667746T1/sl unknown
- 2004-10-04 ZA ZA200602759A patent/ZA200602759B/en unknown
- 2004-10-04 PT PT04775510T patent/PT1667746E/pt unknown
- 2004-10-04 AU AU2004275685A patent/AU2004275685B2/en not_active Ceased
- 2004-10-04 RU RU2006114350/15A patent/RU2349349C2/ru not_active IP Right Cessation
- 2004-10-04 KR KR1020067008504A patent/KR101181535B1/ko not_active Expired - Fee Related
- 2004-10-04 DK DK04775510T patent/DK1667746T3/da active
- 2004-10-04 WO PCT/SE2004/001418 patent/WO2005030283A1/en not_active Ceased
- 2004-10-04 BR BRPI0415004-0A patent/BRPI0415004A/pt not_active IP Right Cessation
2006
- 2006-03-22 IL IL174488A patent/IL174488A0/en not_active IP Right Cessation
- 2006-04-28 NO NO20061899A patent/NO328180B1/no not_active IP Right Cessation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3537986A4 (en) *	2016-11-10	2020-06-03	ViaCyte, Inc.	PDX1 PANCREATIC ENDODERM CELLS IN CELL INSERTION DEVICES AND METHOD THEREFOR
US11623023B2 (en)	2016-11-10	2023-04-11	Viacyte, Inc.	PDX1 pancreatic endoderm cells in cell delivery devices and methods thereof
US12144908B2 (en)	2016-11-10	2024-11-19	Viacyte, Inc.	PDX1 pancreatic endoderm cells in cell delivery devices and methods thereof

Also Published As

Publication number	Publication date
SI1667746T1 (sl)	2009-02-28
US7955613B2 (en)	2011-06-07
CN1859934A (zh)	2006-11-08
SE526959C2 (sv)	2005-11-29
EP1667746A1 (en)	2006-06-14
RU2349349C2 (ru)	2009-03-20
ES2313072T3 (es)	2009-03-01
RS20060235A (sr)	2008-09-29
KR20060107753A (ko)	2006-10-16
AU2004275685A1 (en)	2005-04-07
EP1667746B1 (en)	2008-08-20
UA81982C2 (uk)	2008-02-25
IL174488A0 (en)	2006-08-01
NZ546775A (en)	2008-10-31
BRPI0415004A (pt)	2006-11-28
RU2006114350A (ru)	2007-11-20
CA2539150C (en)	2013-03-26
JP4837563B2 (ja)	2011-12-14
SE0302599D0 (sv)	2003-10-02
DK1667746T3 (da)	2009-01-12
MXPA06003665A (es)	2006-06-05
CA2539150A1 (en)	2005-04-07
DE602004016008D1 (de)	2008-10-02
AU2004275685B2 (en)	2010-05-13
NO20061899L (no)	2006-06-28
ZA200602759B (en)	2007-06-27
JP2007507284A (ja)	2007-03-29
SE0302599L (sv)	2005-04-03
PL1667746T3 (pl)	2009-02-27
KR101181535B1 (ko)	2012-09-10
WO2005030283A1 (en)	2005-04-07
US20060263405A1 (en)	2006-11-23
CN100536937C (zh)	2009-09-09
PT1667746E (pt)	2008-11-06
HK1095542A1 (zh)	2007-05-11
ATE405301T1 (de)	2008-09-15

Publication	Publication Date	Title
EP2125056B1 (en)	2015-11-18	Implant assembly
US5674289A (en)	1997-10-07	Bioartificial pancreas
NO328180B1 (no)	2009-12-28	Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon
CN105324136B (zh)	2018-11-06	用于组织工程的基质和植入物
US20040247640A1 (en)	2004-12-09	Nitric oxide releasing eptfe coated medical device sandwich
US20060008497A1 (en)	2006-01-12	Implantable apparatus having improved biocompatibility and process of making the same
NO300993B1 (no)	1997-09-01	Implantatsammensetning
WO1991000119A1 (en)	1991-01-10	Implantable device
NO309124B1 (no)	2000-12-18	Kunstige biologiske anordninger for frigivelse av hormoner
US10092387B2 (en)	2018-10-09	Implantable device for retaining live cells and providing nutrients thereto
KR20010040427A (ko)	2001-05-15	생적합성 이식물용 조성물 및 방법
HK1095542B (en)	2009-12-11	Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation
Wang et al.	2002	A new vascular prosthesis coated with polyamino‐acid urethane copolymer (PAU) to enhance endothelialization
Kulka	2020	Mussel-Inspired Polyglycerol Coatings for the Prevention of Biomaterial-Related Fouling
Richardson et al.	1980	Hybrid organs
Busscher et al.	1992	Biomaterials Biocompatibility in Health Problems
BUSSCHER¹ et al.	1992	Materia Technica¹ and Biomedical Technology Centre²

Legal Events

Date	Code	Title	Description
2013-05-27	MM1K	Lapsed by not paying the annual fees